Biochemical Recurrence after Radical Prostatectomy
Christian P. Pavlovich, MD, discusses biochemical recurrence in prostate cancer, emphasizing risk stratification and treatment approaches.
Read MoreChristian P. Pavlovich, MD | Sep 2025
Christian P. Pavlovich, MD, discusses biochemical recurrence in prostate cancer, emphasizing risk stratification and treatment approaches.
Read MoreChristian P. Pavlovich, MD | Jun 2025
Christian P. Pavlovich, MD, provides a detailed overview of serum and urinary biomarkers for prostate cancer diagnosis and prognosis.
Read MoreArthur L. Burnett II, MD, MBA, FACS | May 2025
Arthur L. Burnett II, MD, MBA, FACS, reflects on over 30 years of research on priapism.
Read MoreChristian P. Pavlovich, MD, David M. Albala, MD, Andrew W. Hahn, MD, Brian T. Helfand, MD, PhD, Ronald P. Kaufman, Jr., MD and A. Oliver Sartor, MD | May 2025
A panel discusses intermittent versus continuous androgen deprivation therapy (ADT) and its impact on prostate cancer outcomes.
Read MoreChristian P. Pavlovich, MD | Apr 2025
Christian P. Pavlovich, MD, examines the use of TULSA in prostate cancer treatment, highlighting its technique, outcomes, and future potential.
Read More